Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/26/1996 | US5578705 Cytoplasmic antiproteinase-2 coding sequences |
11/26/1996 | US5578704 Bone disorders |
11/26/1996 | US5578703 Dimer proteins which bind to transforming growth factor |
11/26/1996 | US5578702 Toxin active against lepidopteran insects |
11/26/1996 | US5578572 Anti-gram-positive bacterial methods and materials |
11/26/1996 | US5578569 Method of increasing bone growth |
11/26/1996 | US5578564 Nickel-free hemoglobin and methods for producing such hemoglobin |
11/26/1996 | US5578486 Recombinant microbial fertilizer and methods for its production |
11/26/1996 | US5578483 Receptor transcription-repression activity compositions and methods |
11/26/1996 | US5578481 Cloning and characterization of a cardiac adenylyl cyclase |
11/26/1996 | US5578479 Alpha-amylase from hyperthermophilic archaebacterium |
11/26/1996 | US5578478 Recombinant DNA encoding a desulfurization biocatalyst |
11/26/1996 | US5578476 Flavin reductase gene |
11/26/1996 | US5578475 Composition and methods for transfecting eukaryotic cells |
11/26/1996 | US5578473 Recombinant negative strand RNA virus |
11/26/1996 | US5578468 Site-specific RNA cleavage |
11/26/1996 | US5578466 Recombinant co-expression system of protein disulfide isomerase gene, yeast receptor protein ERD2 gene and a foreign product polypeptide gene, and a process for producing the foreign polypeptide using such system |
11/26/1996 | US5578465 Method of using eukaryotic expression vectors comprising the BK virus enhancer |
11/26/1996 | US5578464 Proteins for gene expression with dna sequences |
11/26/1996 | US5578463 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same |
11/26/1996 | US5578461 Genetic engineering; amplification |
11/26/1996 | US5578459 Method and apparatus for collecting a cell sample from a liquid specimen |
11/26/1996 | US5578458 High speed, simple |
11/26/1996 | US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
11/26/1996 | US5578448 Polymerase chain reaction |
11/26/1996 | US5578444 Sequence-directed DNA-binding molecules compositions and methods |
11/26/1996 | US5578270 System for nucleic acid based diagnostic assay |
11/26/1996 | CA2069906C Uncharged morpholino-based polymers having achiral intersubunit linkages |
11/23/1996 | CA2176193A1 Methods for polymerase chain reaction preamplification sterilization by exonucleases in the presence of phosphorothioated primers |
11/21/1996 | WO1996036730A1 Cell death protein |
11/21/1996 | WO1996036722A2 Embedded expression of heterologous proteins |
11/21/1996 | WO1996036721A1 Promoters for gene expression |
11/21/1996 | WO1996036720A1 Recombinant heregulins and their biological functions upon receptor activation |
11/21/1996 | WO1996036719A1 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity |
11/21/1996 | WO1996036718A1 Expression of glycosyltransferase in aspergillus |
11/21/1996 | WO1996036717A2 Dna sequences encoding a lycopene cyclase, antisense sequences derived therefrom and their use for the modification of carotenoids levels in plants |
11/21/1996 | WO1996036716A1 Transgenic plants exhibiting altered flower colour and methods for producing same |
11/21/1996 | WO1996036715A1 A method and nucleotide sequence for transforming microorganisms |
11/21/1996 | WO1996036714A1 Nucleic acid molecule for treating b cell malignant tumor, process for producing the same and utilization of the same |
11/21/1996 | WO1996036713A2 Eck receptor ligands |
11/21/1996 | WO1996036712A1 Recombinant baculovirus insecticides |
11/21/1996 | WO1996036711A2 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
11/21/1996 | WO1996036710A1 Bmp-15 compositions |
11/21/1996 | WO1996036709A1 Transforming growth factor alpha hii |
11/21/1996 | WO1996036706A1 A method for large scale plasmid purification |
11/21/1996 | WO1996036705A1 Viral vectors |
11/21/1996 | WO1996036702A2 Soluble, active hepatitis c virus protease |
11/21/1996 | WO1996036698A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
11/21/1996 | WO1996036697A1 Transcriptional control sequences and methods |
11/21/1996 | WO1996036695A1 Ataxia-telangiectasia gene |
11/21/1996 | WO1996036692A1 In vivo selection of rna-binding peptides |
11/21/1996 | WO1996036691A1 Ataxia-telangiectasia gene and its genomic organization |
11/21/1996 | WO1996036644A1 Obesity gene product |
11/21/1996 | WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
11/21/1996 | WO1996036436A1 Remotely programmable matrices with memories and uses thereof |
11/21/1996 | WO1996036367A1 Composition and method for tumor imaging |
11/21/1996 | WO1996036366A1 Gene therapy for effector cell regulation |
11/21/1996 | WO1996036365A1 Gene therapy of hepatocellular carcinoma through cancer-specific gene expression |
11/21/1996 | WO1996036364A1 Recombinant viral vector system |
11/21/1996 | WO1996036363A1 Method for pharmaceutical delivery |
11/21/1996 | WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
11/21/1996 | WO1996036360A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
11/21/1996 | WO1996036355A1 Leptospira membrane proteins |
11/21/1996 | WO1996036353A1 Method for deriving ribozymes from nucleotide sequences and ribozymes derived thereof |
11/21/1996 | WO1996036244A1 Application of phospholipases in animal feed |
11/21/1996 | WO1996036221A2 Insect control with multiple toxins |
11/21/1996 | WO1996031612A3 Process for selection of transgenic plant cells |
11/21/1996 | WO1996030507A3 Vectors for differential expression |
11/21/1996 | WO1996030042A3 Methods of treating inflammation and compositions therefor |
11/21/1996 | WO1996029605A3 Compounds and methods for the dectection of t. cruzi infection |
11/21/1996 | WO1996029407A3 Cellubrevin homologs |
11/21/1996 | WO1996021017A3 Isolated dna encoding enzyme for phage resistance |
11/21/1996 | WO1996015269A3 Mesoscale polynucleotide amplification devices |
11/21/1996 | DE19530272C1 Monoclonal antibody specific for cell-surface glyco-protein MGC-24 |
11/21/1996 | CA2221348A1 Transcriptional control sequences and methods |
11/21/1996 | CA2221305A1 Gene therapy for effector cell regulation |
11/21/1996 | CA2221303A1 Obesity gene product |
11/21/1996 | CA2221292A1 Recombinant viral vector system |
11/21/1996 | CA2221271A1 Expression of glycosyltransferase in aspergillus |
11/21/1996 | CA2221269A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
11/21/1996 | CA2220867A1 A method for large scale plasmid purification |
11/21/1996 | CA2220674A1 Leptospira membrane proteins |
11/21/1996 | CA2220010A1 Bmp-15 compositions |
11/21/1996 | CA2219984A1 Cell death protein |
11/21/1996 | CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
11/21/1996 | CA2218898A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd19 antibodies |
11/21/1996 | CA2218718A1 In vivo selection of rna-binding peptides |
11/21/1996 | CA2217969A1 Ataxia-telangiectasia gene and its genomic organization |
11/21/1996 | CA2217965A1 Ataxia-telangiectasia gene |
11/21/1996 | CA2217020A1 Recombinant heregulins and their biological functions upon receptor activation |
11/21/1996 | CA2216645A1 Remotely programmable matrices with memories and uses thereof |
11/21/1996 | CA2206984A1 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity |
11/21/1996 | CA2202668A1 Transgenic plants exhibiting altered flower colour and methods for producing same |
11/20/1996 | EP0743520A2 Novel uses for GAL4-receptor constructs |
11/20/1996 | EP0743367A2 Gene expression analysis |
11/20/1996 | EP0743366A1 Determination of Listeria using recombinant bacteriophages |
11/20/1996 | EP0743365A2 Process for efficiently producing transglutaminase through DNA recombination |
11/20/1996 | EP0743364A2 Nucleic acid fragments derived form the HIV-1 genome, corresponding fragments and their application as reactives for risk evaluation of HIV-1 mother-foetal transmission |
11/20/1996 | EP0743321A2 Obesity gene product |
11/20/1996 | EP0743318A1 Novel anti-hiv agent |